ProQR Therapeutics PRQR
NASDAQ PRQR
$1.63 +0.00 (+0.31%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Invested Capital (2013 - 2026)

Updated

ProQR Therapeutics (PRQR) posted Invested Capital of $98.21 million for the quarter ended Jun 30, 2026, up 21.0% from $81.17 million a year earlier and up 97.2% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Invested Capital (2013 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, ProQR Therapeutics' Invested Capital came in at $61.29 million, down 39.2% from the prior year.

  • Annual Invested Capital shows a five-year compound annual growth rate of -6.2% (years ended Dec 2020 to Dec 2025).
  • In prior years, ProQR Therapeutics' Invested Capital was $100.81 million in the year ended Dec 31, 2024 (+104.0%), $49.42 million in the year ended Dec 31, 2023 (-33.9%), $74.78 million in the year ended Dec 31, 2022 (-58.8%) and $181.57 million in the year ended Dec 31, 2021 (+115.3%).
  • The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Invested Capital since the quarter ended Dec 31, 2024.
  • On a year-over-year basis, Invested Capital increased in five of the last eight quarters, with growth averaging 41.7%.
  • The strongest year-over-year quarter for Invested Capital in the past five years was the quarter ended Mar 31, 2022, with growth of 169.2%; the weakest was the quarter ended Dec 31, 2022, with a decline of 58.8%.
  • According to Business Quant data, Invested Capital for the three prior quarters was $49.81 million (quarter ended Mar 31, 2026), $63.14 million (quarter ended Dec 31, 2025) and $72.33 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 134.01 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 64.89 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 50.26 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 38.08 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 148.69 Bn
10 ProQR Therapeutics 171.74 Mn -291.86 Mn - 98.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 98.21 Mn
Mar 31, 2026 49.81 Mn
Dec 31, 2025 63.14 Mn
Sep 30, 2025 72.33 Mn
Jun 30, 2025 81.17 Mn
Mar 31, 2025 87.93 Mn
Dec 31, 2024 99.53 Mn
Sep 30, 2024 32.39 Mn
Jun 30, 2024 40.16 Mn
Mar 31, 2024 42.57 Mn
Dec 31, 2023 49.15 Mn
Sep 30, 2023 56.14 Mn
Jun 30, 2023 63.15 Mn
Mar 31, 2023 69.96 Mn
Dec 31, 2022 72.39 Mn
Sep 30, 2022 75.29 Mn
Jun 30, 2022 143.38 Mn
Mar 31, 2022 164.08 Mn
Dec 31, 2021 175.52 Mn
Sep 30, 2021 173.74 Mn
API Access

ProQR Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=PRQR&period=max&api_key=YOUR_API_KEY